Diligence memo · auto-generated · as of July 2, 2026
Cen Biotech Inc
Cen Biotech Inc has raised $2.6M over 1 round; too few niche peers to rank its valuation yet.
Businessfiled
Cen Biotech Inc operates in Biotech, based in Windsor.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Cen Biotech Inc has raised $2.6M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.6M on 2016-03-24.
Most recent recorded round closed around 2016-03-24.
Valuation (modeled)modeled
Provath models Cen Biotech Inc at approximately $117M (range $1.9M–$919M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Last raise 10.3 yr ago; this sector typically re-raises about every 11 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 75% of Biotech peers (233 compared).
Modeled value ranks above 89% of those peers.
Closest niche peers: Ambra Bioscience LLC.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.